Sands Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-110,955
Closed -$2.96M 79
2020
Q1
$2.96M Sell
110,955
-778,191
-88% -$23.8M 0.01% 76
2019
Q4
$28.8M Hold
889,146
0.08% 65
2019
Q3
$23.5M Buy
+889,146
New +$35M 0.08% 66

Other funds holding HCAT

Sands Capital Management's HCAT Position: Q2 2020 in Review

Sands Capital Management sold out of Health Catalyst (HCAT) in Q2 2020, closing a stake of 110,955 shares — an estimated $2.96M sold.

Sands Capital Management first reported a position in HCAT in Q3 2019 and held it in 3 quarters. The position peaked at $28.8M in Q4 2019. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.

  • Sands Capital Management reported no remaining Health Catalyst position as of Q2 2020 after selling out during the quarter.
  • Sands Capital Management sold 110,955 Health Catalyst shares in Q2 2020, an estimated $2.96M.
  • Sands Capital Management first reported a position in Health Catalyst in Q3 2019 and held it in 3 quarters.
  • Sands Capital Management's Health Catalyst position peaked at $28.8M in Q4 2019.
  • 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.

Based on Sands Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.